FDA inspection
Amgen Inc.: FDA inspection ending Jan 17, 2024
FDA inspection 1228575 · No Action Indicated (NAI) · New Albany, OH
Key facts
| Inspection ID | 1228575 |
|---|---|
| Firm | Amgen Inc. |
| FEI number | 3020740318 |
| Address | 4150 Ganton Parkway |
| City | New Albany |
| State | OH |
| ZIP | 43054 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Jan 17, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data